Skip to main content
SpringerLink
Log in

Pharmacokinetics of Anti-Infective Agents in Paediatric Patients

  • Review Article
  • Clinical Pharmacokinetics in Special Populations
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

Summary

Various differences in drug disposition exist between children and adults. For example, the volume of distribution (Vd) for many drugs is larger in children than in adults. Other parameters, including excretion and elimination may be altered in children compared with adults.

The penicillins and cephalosporins are used commonly for the treatment of infection in paediatric patients. The increased Vd in children contributes to the increased elimination half-life of these agents. Clearance of the acylureido-penicillins is increased in children with cystic fibrosis, a disease that decreases the elimination half-life for these drugs. Aminoglycosides distribute into extracellular fluid and their pharmacokinetic profile is affected by changes in Vd. The Vd for aminoglycosides is slightly higher in children than in adults. Children with cystic fibrosis, bums, or cancer have higher clearance rates and larger Vd values for aminoglycosides.

Few data in the literature address the pharmacokinetics of other anti-infective agents, including vancomycin, teicoplanin, erythromycin, metronidazole, chloramphenicol, and cotrimoxazole (trimethoprim-sulfamethoxazole), in children. Similarly, there is little information regarding the pharmacokinetic profile of antivirals and antifungals in children.

Dosage guidelines are available to enable the clinician to initiate anti-infective therapy in children. Subsequent dosage requirements may change based on the patient’s current clinical condition.

Although several studies have investigated the pharmacokinetics of anti-infectives in neonates and adults, data for children are limited. Therefore, further studies are required so that the ever growing arsenal of anti-infectives can be administered appropriately to children.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Acocella G. Clinical pharmacokinetics of rifampicin. Clinical Pharmacokinetics 3: 108–127, 1978

    Article  PubMed  CAS  Google Scholar 

  • Alford RH. Antimycobacterials. In Mandell et al. (Eds) Principles and practices of infectious diseases, Vol 1, pp. 350–360, Churchill Livingston, New York, 1990

    Google Scholar 

  • Aranda JV, MacLeod SM, Renton KW, Eade NR. Hepatic microsomal drug oxidation and electron transport newborn infants. Journal of Pediatrics 85: 534–542, 1974

    Article  PubMed  CAS  Google Scholar 

  • Asmar BI, Thirumoorthi MC, Buckley JA, Kobos DM, Dajani AS. Cefotaxime diffusion into cerebrospinal fluid of children with meningitis. Antimicrobial Agents and Chemotherapy 28: 138–140, 1985

    Article  PubMed  CAS  Google Scholar 

  • Assael BM. Pharmacokinetics and drug distribution during postnatal development. Pharmacology and Therapeutics 18: 159–197, 1982

    Article  PubMed  CAS  Google Scholar 

  • Atkinson AJ, Bennett JE. Amphotericin B pharmacokinetics in humans. Antimicrobial Agents and Chemotherapy 13: 271–288, 1978

    Article  PubMed  Google Scholar 

  • Brammer KW, Farrow PR, Faulkner JK. Pharmacokinetics and tissue penetration of fluconazole in humans. Review of Infectious Disease 12 (Suppl. 3): S318–S326, 1990

    Article  Google Scholar 

  • Bauer L, Piecoro JJ, Wilson HD. Gentamicin and tobramycin pharmacokinetics in patients with cystic fibrosis. Clinical Pharmacy 2: 262–264, 1983

    PubMed  CAS  Google Scholar 

  • Begue P, Quinou F, Quinet B. Efficacy and pharmacokinetics of timentin in paediatric infections. Journal of Antimicrobial Chemotherapy 17 (Suppl. C): 81–91, 1986

    PubMed  Google Scholar 

  • Begue PC, Baron S, Challier P, Fontaine JL, Lasfargues G. Pharmacokinetic and clinical evaluation of imipenem/cilastatin in children and neonates. Scandinavian Journal of Infectious Disease 52 (Suppl. 52): 40–45, 1987

    CAS  Google Scholar 

  • Bennett JE. Antifungals. In Mandell et al. (Eds) Principles and practices of infectious diseases, Vol. 1, pp. 361–369, Churchill Livingston, New York, 1990

    Google Scholar 

  • Benson JM, Nahata MC. Pharmacokinetics of amphotericin B in children. Antimicrobial Agents and Chemotherapy 33: 1989–1993, 1989

    Article  PubMed  CAS  Google Scholar 

  • Bergan T, Thorsteinsson SB, Steingrimsson O. Dose-dependent pharmacokinetics of azlocillin compared to mezlocillin. Chemotherapy 28: 160–170, 1982

    Article  PubMed  CAS  Google Scholar 

  • Blum MR, Liao SHT, de Miranda P. Overview of acyclovir pharmacokinetic disposition in adults and children. American Journal of Medicine 73(1A): 186–192, 1982

    Article  PubMed  CAS  Google Scholar 

  • Borin MT. A review of the pharmacokinetics of cefpodoxime proxetil. Drugs 42 (Suppl. 3): 13–21, 1991

    Article  PubMed  CAS  Google Scholar 

  • Borin MT, Hughes GS, Spillers CR, Patel RK. Pharmacokinetics of cefpodoxime in plasma and skin blister fluid following oral dosing of cefpodoxime proxetil. Antimicrobial Agents and Chemotherapy 34: 1094–1099, 1990

    Article  PubMed  CAS  Google Scholar 

  • Bosso JA, Relling MV, Tounsend PL, Strand LM. Intrapatient variation in aminoglycoside disposition in cystic fibrosis. Clinical Pharmacokinetics 6: 54–58, 1987

    CAS  Google Scholar 

  • Bosso JA, Saxton BA, Herbst JJ. Azlocillin pharmacokinetics in patients with cystic fibrosis. Antimicrobial Agents and Chemotherapy 25: 630–632, 1984

    Article  PubMed  CAS  Google Scholar 

  • Bruckner O, Collmann H, Borner K. Cefotaxime levels in ventricular cerebrospinal fluid, determined by bioassay and by high-performance liquid chromatography. Chemotherapy 29: 237–243, 1983

    Article  PubMed  CAS  Google Scholar 

  • Bums L, Hodgman J. Studies of prematures given erythromycin estolate. American Journal of Diseases of Childhood 106: 280–288, 1963

    Google Scholar 

  • Burton ME, Chow MS, Platt D, Day RB, Brater DC, et al. Accuracy of Bayesian and Sawchuk-Zaske dosing methods for gentamicin. Clinical Pharmacy 5: 143–149, 1986

    PubMed  CAS  Google Scholar 

  • Christiansen KJ, Bemard EM, Gold JWM, et al. Distribution and activity of amphotericin B in humans. Journal of Infectious Disease 152: 1037–1043, 1985

    Article  CAS  Google Scholar 

  • Davis RL, Koup JR, Williams-Warren J, et al. Pharmacokinetics of ciprofloxacin in cystic fibrosis. Antimicrobial Agents and Chemotherapy 31: 915–919, 1987

    Article  PubMed  CAS  Google Scholar 

  • Delage G, Desautels L, Legault S, Lasalle R, Lapierre J, et al. Individualized aminoglycoside dosage regimens in patients with cystic fibrosis. Drug Intelligence and Clinical Pharmacy 22: 386–389, 1988

    PubMed  CAS  Google Scholar 

  • Donowitz GR, Mandell GL. Cephalosporins. In Mandell et al. (Eds) Principles and practices of infectious diseases, Vol. 1, pp. 246–256, Churchill Livingston, New York, 1990

    Google Scholar 

  • Edwards DJ, Pancorbo S. Routine monitoring of serum vancomycin concentrations: waiting for proof of its value. Clinical Pharmacy 6: 652–654, 1987

    PubMed  CAS  Google Scholar 

  • Elliot RB, Stokes EJ, Maxwell GM. Ampicillin in paediatrics. Archives of Diseases in Childhood 39: 101–105, 1964

    Article  Google Scholar 

  • Fekety R. Vancomycin and teicoplanin. In Mandell et al. (Eds) Principles and practices of infectious diseases, Vol. 1, pp. 317–322, Churchill Livingston, New York, 1990

    Google Scholar 

  • Fichter EG, Curtis JA. Sulfonamide administration in newborn and premature infants. Pediatrics 18: 50–58, 1956

    PubMed  CAS  Google Scholar 

  • Finegold SM, Mathisen GE. Metronidazole. In Mandell et al. (Eds) Principles and practices of infectious diseases, Vol. 1, pp. 303–307, Churchill Livingston, New York, 1990

    Google Scholar 

  • Fletcher C, Sawchuk R, Chinnock B, de Miranda P, Balfour HH. Human pharmacokinetics of the antiviral drug DHPG. Clinical Pharmacology and Therapeutics 40: 281–286, 1986

    Article  PubMed  CAS  Google Scholar 

  • Friis-Hansen B. Body water compartments in children: changes during growth and related changes in body composition. Pediatrics 28: 169–181, 1961

    PubMed  CAS  Google Scholar 

  • Friis-Hansen B. In vivo measurements and biochemical data correlated to differential anatomical growth. Pediatrics 47: 264–274, 1971

    PubMed  CAS  Google Scholar 

  • Fujii R. Clinical trials of cefpodoxime proxetil suspension in paediatrics. Drugs 42 (Suppl. 3): 57–60, 1991

    Article  PubMed  Google Scholar 

  • Gehanno P, Andrews JM, Ichow F, Sultan E, Lenfant B. Concentrations of cefpodoxime in plasma and tonsillar tissue after a single oral dose of cefpodoxime proxetil. Journal of Antimicrobial Chemotherapy 26 (Suppl. E): 47–51, 1990

    PubMed  Google Scholar 

  • Ginsburg CM, Eichenwald HF. Erythromycin: a review of its uses in pediatric practice. Journal of Pediatrics 89: 872–884, 1976

    Article  PubMed  CAS  Google Scholar 

  • Goldfarb J, Wormser GP, Inchiosa MA. Single-dose pharmacokinetics of oral ciprofloxacin in patients with cystic fibrosis. Clinical Pharmacology 26: 222–226, 1986.

    CAS  Google Scholar 

  • Hayden FG, Douglas RG. Antiviral agents. In Mandell et al. (Eds) Principles and practices of infectious diseases, Vol. 1, pp. 370–392, Churchill Livingston, New York, 1990

    Google Scholar 

  • Heimann G. Enteral absorption and bioavailability in children in relation to age. European Journal of Clinical Pharmacology 18: 43–50, 1980

    Article  PubMed  CAS  Google Scholar 

  • Higa GM, Murray WE. Alterations in aminoglycoside pharmacokinetics in patients with cancer. Clinical Pharmacy 6: 393–396, 1987

    Google Scholar 

  • Hilligoss DM. Neonatal pharmacokinetics. In Evans et al. (Eds) Applied pharmacokinetics: principles of therapeutic drug monitoring, p. 76, Applied Therapeutics, San Francisco, 1980

    Google Scholar 

  • Hoogkamp-Korstanje JAA, van der Laag J. Piperacillin and tobramycin in the treatment of pseudomonas lung infections in cystic fibrosis. Journal of Antimicrobial Chemotherapy 12: 175–183, 1983

    Article  PubMed  CAS  Google Scholar 

  • Huang NN, High RH. Comparison of serum levels following the administration of oral and parenteral preparations of penicillin to infants and children of various age groups. Journal of Pediatrics 42: 657–668, 1953

    Article  PubMed  CAS  Google Scholar 

  • Humphrey MJ, Jevons S, Tarbit MH. Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans. Journal of Antimicrobial Chemotherapy 28: 648–653, 1985

    Article  CAS  Google Scholar 

  • Hyvarinen M, Zeltzer P, Oh V, Stiehm ER. Influence of gestational age on serum levels of alpha-1 fetoprotein, IgG globulin, and albumin in newborn infants. Journal of Pediatrics 82: 430–437, 1973

    Article  PubMed  CAS  Google Scholar 

  • Ings RM, Fillastre JP, Godin M, Leroy, Humbert G. The pharmacokinetics of cefotaxime and its metabolites in subjects with normal and impaired renal function. Review of Infectious Disease 4: S379–S391, 1982

    Article  Google Scholar 

  • Jacobs RF, Keams GL. Cefotaxime and desacetylcefotaxime in neonates and children: a review of microbiologic, pharmacokinetic, and clinical experience. Diagnostic Microbiology and Infectious Disease 12: 93–99, 1989

    Article  PubMed  CAS  Google Scholar 

  • Jacobs RF, Keams GL, Brown AL, Longee DC. Cerebrospinal fluid penetration of imipenem and cilastatin (primaxin) in children with central nervous system infections. Antimicrobial Agents and Chemotherapy 29: 670–674, 1986

    Article  PubMed  CAS  Google Scholar 

  • Jacobs RF, Keams GL, Trang JM, Brown AL, Manner B, et al. Single-dose pharmacokinetics of imipenem in children. Journal of Pediatrics 105: 996–1001, 1984

    Article  PubMed  CAS  Google Scholar 

  • Joshi M, Anthony WC, Tenney JH, Drusano GL, Caplan BS. Double blind, multi-center, prospective trial comparing ceftazidime with moxalactam in the treatment of serious gram negative infections. Antimicrobial Agents and Chemotherapy 30: 90–95, 1986

    Article  PubMed  CAS  Google Scholar 

  • Jusko WJ, Mosovich LL, Gerbracht LM, Mattar ME, Yaffe SJ. Enhanced renal excretion of dicloxacillin in patients with cystic fibrosis. Pediatrics 56: 1038–1044, 1975

    PubMed  CAS  Google Scholar 

  • Kaplan EL, Berrios X, Speth J, Sieferman T, Guzman B, et al. Pharmacokinetics of benzathine penicillin G: semm levels during the 28 days after intramuscular injection of 1,200,000 units. Journal of Pediatrics 115: 146–150, 1989

    Article  PubMed  CAS  Google Scholar 

  • Kauffman RE, Miceli JN, Strebel L, Buckley JA, Done AK, et al. Pharmacokinetics of chloramphenicol and chloramphenicol succinate in infants and children. Journal of Pediatrics 98: 315–320, 1981

    Article  PubMed  CAS  Google Scholar 

  • Keams GL, Hilman BC, Wilson JT. Dosing implications of altered gentamicin disposition in patients with cystic fibrosis. Journal of Pediatrics 100: 312–318, 1982

    Article  Google Scholar 

  • Kelly HB, Menendez R, Fan L, Murphy S. Pharmacokinetics of tobramycin in cystic fibrosis. Journal of Pediatrics 100: 318–321, 1982

    Article  PubMed  CAS  Google Scholar 

  • Klinger W. Biotransformation of drugs and other xenobiotics during postnatal development. Pharmacology and Therapeutics 16: 377–429, 1982

    Article  PubMed  CAS  Google Scholar 

  • Kramer WG, Pickering LK, Culbert S, Frankel LS. Mezlocillin pharmacokinetics in pediatric oncology patients. Antimicrobial Agents and Chemotherapy 25: 62–64, 1984

    Article  PubMed  CAS  Google Scholar 

  • Kuhn RJ, Palmejar A, Kanga JF. Tolerability of ciprofloxacin in pediatric patients with cystic fibrosis. Advances in Antimicrobial and Antineoplastic Chemotherapy 11: 269–271, 1992

    Google Scholar 

  • Lee JW, Seigel NL, Amantea M, Whitcomb P, Pizzo PA, et al. Safety and pharmacokinetics of fluconazole in children with neoplastic diseases. Journal of Pediatrics 120: 987–993, 1992

    Article  PubMed  CAS  Google Scholar 

  • Lemerle S, de La Rocque F, Lamy R, Fremaux A, Bemaudin F, et al. Teicoplanin in combination therapy for febrile episodes in neutropenic and non-neutropenic paediatric patients. Journal of Antimicrobial Chemotherapy 21 (Suppl. A): 113–116, 1988

    PubMed  Google Scholar 

  • Levy J, Smith AL, Koup JR, Williams-Warren J, Ramsey B. Disposition of tobramycin in patients with cystic fibrosis: a prospective controlled study. Journal of Pediatrics 105: 117–124, 1984

    Article  PubMed  CAS  Google Scholar 

  • Lindsay CA, Bosso JA, Optimisation of Antibiotic Therapy in Cystic Fibrosis Patients: Pharmacokinetic Considerations. Clinical Pharmacokinetics 24(6): 496–506, 1993

    Article  PubMed  CAS  Google Scholar 

  • Loirat P, Rohan J, Baillet A, Beaufils F, David R, et al. Increased glomerular filtration rate in patients with major burns and its effect on the pharmacokinetics of tobramycin. New England Journal of Medicine 299: 915–919, 1978

    Article  PubMed  CAS  Google Scholar 

  • Lyman CA, Walsh TJ. Systemically administered antifungal agents: a review of their clinical pharmacology and therapeutic applications. Drugs 44: 9–35, 1992

    Article  PubMed  CAS  Google Scholar 

  • MacDonald NE, Anas NG, Peterson RG, Schwartz RH, Brooks JG, et al. Renal clearance of gentamicin in cystic fibrosis. Journal of Pediatrics 103: 985–995, 1983

    Article  PubMed  CAS  Google Scholar 

  • Malmborg AS, Alfredsson H, Kusoffsky E, Strandvik B. Azlocillin and gentamicin in respiratory tract infections with pseudomonas aeruginosa in patients with cystic fibrosis. Scandinavian Journal of Infectious Diseases (Suppl. 29): 64–69, 1981

    Google Scholar 

  • McCracken GH, Ginsburg CM, Clahsen JC, Thomas ML. Pharmacologic evaluation of orally administered antibiotics in infants and children: effect of feeding on bioavailability. Pediatrics 62: 783–743, 1978

    Google Scholar 

  • McGee SM, Kaplan SL, Mason EG. Ventricular fluid concentrations of vancomycin in children after intravenous and intraventricular administration. Pediatric Infectious Disease Journal 9: 138–139, 1990

    Article  PubMed  CAS  Google Scholar 

  • Milsap RL, Szefler SJ. Special pharmacokinetic considerations in children. In Evans et al.(Eds) Applied pharmacokinetics-principles of therapeutic drug monitoring, pp. 294–330, Applied Therapeutics, Spokane, Washington, 1986

    Google Scholar 

  • Morselli PL, Franco-Morselli R, Bossi L. Clinical pharmacokinetics in newborns and infants: age-related differences and therapeutic implications. Clinical Pharmacokinetics 5: 485–527, 1980

    Article  PubMed  CAS  Google Scholar 

  • Nahata MC. Lack of nephrotoxicity in pediatric patients receiving concurrent vancomycin and aminoglycoside therapy. Chemotherapy 33: 302–304, 1987a

    Article  PubMed  CAS  Google Scholar 

  • Nahata MC. Serum concentrations and adverse effects of chloramphenicol in pediatric patients. Chemotherapy 33: 322–327, 1987b

    Article  PubMed  CAS  Google Scholar 

  • Nahata MC. Chloramphenicol. In Evans et al. (Eds) Applied pharmacokinetics — principles of therapeutic drug monitoring, pp. 16–1, 16-24, Applied Therapeutics, Spokane, Washington, 1992

    Google Scholar 

  • Nahata MC, Powell DA. Bioavailability and clearance of chloramphenicol after intravenous chloramphenicol succinate. Clinical Pharmacology and Therapeutics 30: 368–372, 1981

    Article  PubMed  CAS  Google Scholar 

  • Nelson JD, Kesmiesz H, Shelton S, Woodman E. Clinical pharmacology and efficacy of ticarcillin in infants and children. Pediatrics 61: 858–863, 1978

    PubMed  CAS  Google Scholar 

  • Nelson JD, Shelton S, Kusmiesz HT, Haltalin KC. Absorption of ampicillin and nalidixic acid by infants and children with acute shigellosis. Clinical Pharmacology and Therapeutics 13: 879–886, 1972

    PubMed  CAS  Google Scholar 

  • Neu HC. Penicillins. In Mandell et al. (Eds) Principles and practices of infectious diseases, Vol. 1, pp. 230–245, Churchill Livingston, New York, 1990

    Google Scholar 

  • O’Connor WJ, Warren GH, Edrada LS, Mandala PS, Rosenman SB. Serum concentrations of sodium nafcillin in infants during the perinatal period. Antimicrobial Agents and Chemotherapy 5: 220–222, 1966

    Google Scholar 

  • O’Connor WJ, Warren GH, Mandala PS, Edrada LS, Rosenman SB. Serum concentrations of nafcillin in newborn infants and children. Antimicrobial Agents and Chemotherapy 1964: 188–191, 1965

    Google Scholar 

  • Paap CM, Nahata MC. Clinical pharmacokinetics of antibacterial drugs in neonates. Clinical Pharmacokinetics 19: 280–318, 1990

    Article  PubMed  CAS  Google Scholar 

  • Paap CM, Nahata MC, Mentser MA, Mahan JD, Puri SK, et al. Pharmacokinetics of cefotaxime and its active metabolite in children with renal dysfunction. Antimicrobial Agents and Chemotherapy 35: 1879–1883, 1991

    Article  PubMed  CAS  Google Scholar 

  • Patamasucon P, Kaojarem S, Kusmiesz H, Nelson JD. Pharmacokinetics of erythromycin ethylsuccinate and estolate in infants under 4 months of age. Antimicrobial Agents and Chemotherapy 19: 736–739, 1981

    Article  PubMed  CAS  Google Scholar 

  • Pickering LK, Hoecker JL, Kramer WG, Kohl S, Cleary TG. Clinical pharmacology of two chloramphenicol preparations in children: sodium succinate (iv) and palmitate (oral) esters. Journal of Pediatrics 96: 757–761, 1980

    Article  PubMed  CAS  Google Scholar 

  • Pickering LK, Kramer WG, Armes DA, Frankel LS, Townsend IR, et al. Clinical pharmacology and efficacy of mezlocillin in paediatric patients with malignancy. Journal of Antimicrobial Chemotherapy 9 (Suppl. A): 245–250, 1982

    PubMed  Google Scholar 

  • Pickering LK, O’Connor DM, Anderson D, Bairan AC, Feigin RD, et al. Clinical and pharmacologic evaluation of cefazolin in children. Journal of Infectious Diseases 128 (Suppl.): S407–S414, 1973

    Article  PubMed  Google Scholar 

  • Prince AS, Neu HC. Use of piperacillin, a semisynthetic penicillin, in the therapy of acute exacerbations of pulmonary disease in patients with cystic fibrosis. Journal of Pediatrics 97: 148–151, 1980

    PubMed  CAS  Google Scholar 

  • Reed MD, Aronoff SC, Myers CM, Husak MP, Bertino JS, et al. Developmental pharmacokinetics of moxalactam. Antimicrobial Agents and Chemotherapy 24: 383–387, 1983

    Article  PubMed  CAS  Google Scholar 

  • Reed MD, Stem RC, Bertino JS, Myers CM, Yamashita TS, et al. Dosing implications of rapid elimination of trimethoprim-sulfamethoxazole in patients with cystic fibrosis. Journal of Pediatrics 104: 303–307, 1984

    Article  PubMed  CAS  Google Scholar 

  • Reed MD, Stem RC, Myers CM, et al. Lack of unique ciprofloxacin pharmacokinetic characteristics in patients with cystic fibrosis. Journal of Clinical Pharmacology 28: 691–699, 1988

    PubMed  CAS  Google Scholar 

  • Robertson A, Fink S, Karp W. Effect of cephalosporins on bilirubinalbumin binding. Journal of Pediatrics 112: 291–294, 1988

    Article  PubMed  CAS  Google Scholar 

  • Romagnoli MF, Flynn K, Siber GR, Goldmann DA. Moxalactam pharmacokinetics in children. Antimicrobial Agents and Chemotherapy 22: 47–50, 1982

    Article  PubMed  CAS  Google Scholar 

  • Rubenson A, Rosetzsky A. Single dose prophylaxis with metronidazole in infants during abdominal surgery: a pharmacokinetic study. European Journal of Clinical Pharmacology 29: 625–628, 1986

    Article  PubMed  CAS  Google Scholar 

  • Sack CM, Koup JR, Smith AL. Chloramphenicol pharmacokinetics in infants and young children. Pediatrics 66: 579–584, 1980

    PubMed  CAS  Google Scholar 

  • Schaad UB, McCracken GH, Nelson JD. Clinical pharmacology and efficacy of vancomycin in pediatric patients. Journal of Pediatrics 96: 119–126, 1980

    Article  PubMed  CAS  Google Scholar 

  • Schaad UB, McCracken GH, Threlkeld N, Thomas ML. Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants. Journal of Pediatrics 98: 129–136, 1981

    Article  PubMed  CAS  Google Scholar 

  • Schaad UB, Stoeckel K. Single-dose pharmacokinetics of ceftriaxone in infants and young children. Antimicrobial Agents and Chemotherapy 21: 248–253, 1982

    Article  PubMed  CAS  Google Scholar 

  • Schaad UB, Stoupis C, Wedgwood J. Clinical, radiologic and magnetic resonance monitoring for skeletal toxicity in pediatric patients with cystic fibrosis receiving a three-month course of ciprofloxacin. Pediatric Infectious Disease 10: 723–729, 1991

    CAS  Google Scholar 

  • Schluter G. Toxicology of ciprofloxacin. In Neu & Weuta (Eds) First international ciprofloxacin workshop, Vol. 24, pp. 61–70, Current Clinical Practice Series, Exerpta Medica, Amsterdam, 1986

    Google Scholar 

  • Schrinner E, Limbert M, Benasse L, Lutz A. Antibacterial activity of cefotaxime and other newer cephalosporins (in vitro and in vivo). Journal of Antimicrobial Chemotherapy 6 (Suppl. A): 25–30, 1980

    PubMed  CAS  Google Scholar 

  • Shevchuk YM, Taylor DM. Aminoglycoside volume of distribution in pediatric patients. Annals of Pharmacotherapy 24: 273–276, 1990

    PubMed  CAS  Google Scholar 

  • Siber GR, Echeverria P, Smith AL, Paisley JW, Smith DH. Pharmacokinetics of gentamicin in children and adults. Journal of Infectious Diseases 132: 637–651, 1975

    Article  PubMed  CAS  Google Scholar 

  • Skaer TL. Dosing considerations in the pediatric patient. Clinical Therapeutics 13: 526–544, 1991

    PubMed  CAS  Google Scholar 

  • Sommadossi J, Bevan R, Ling T, Lee F, Mastre B, et al. Clinical pharmacokinetics of ganciclovir in patients with normal and impaired renal function. Reviews of Infectious Diseases 10: S507–S514, 1988

    Article  PubMed  Google Scholar 

  • Spino M. Pharmacokinetics of drugs in cystic fibrosis. In Gershwin (Ed.) Clinical Reviews in Allergy, Vol. 9, pp. 169–210, Humana Press, Clifton, New Jersey, 1991

    Google Scholar 

  • Spino M, Chai RP, Isles AF, Theissen JJ, Tesoro A, et al. Cloxacillin absorption and disposition in cystic fibrosis. Journal of Pediatrics 105: 829–835, 1984

    Article  PubMed  CAS  Google Scholar 

  • Starke JR, Mason EO, Kramer WG, et al. Pharmacokinetics of amphotericin B in infants and children. Journal of Infectious Disease 155: 766–774, 1987

    Article  CAS  Google Scholar 

  • Steele RW, Eyre LB, Bradsher RW, Weinfeld RE, Patel I, et al. Pharmacokinetics of ceftriaxone in pediatric patients with meningitis. Antimicrobial Agents and Chemotherapy 23: 191–194, 1983

    Article  PubMed  CAS  Google Scholar 

  • Steigbigel NA. Erythromycins, lincomycin, and clindamycin. In Mandell et al. (Eds) Principles and practices of infectious diseases, Vol. 1, pp. 308–316, Churchill Livingston, New York, 1990

    Google Scholar 

  • Stewart CF, Hampton EM. Effect of maturation on drug disposition in pediatric patients. Clinical Pharmacy 6: 548–564, 1987

    PubMed  CAS  Google Scholar 

  • Sullender WM, Arvin AM, Diaz PS, Connor JD, Straube R, et al. Pharmacokinetics of acyclovir suspension in infants and children. Antimicrobial Agents and Chemotherapy 31: 1722–1726, 1987

    Article  PubMed  CAS  Google Scholar 

  • Tarral C, Jehl F, Tarrai A, Simeoni U, Monteil H, et al. Pharmacokinetics of teicoplanin in children. Journal of Antimicrobial Chemotherapy 21 (Suppl. A): 47–51, 1988

    PubMed  Google Scholar 

  • Thirumoorthi MC, Asmar BI, Buckley JA. Pharmacokinetics of intravenously administered piperacillin in preadolescent children. Journal of Pediatrics 102: 941–946, 1983

    Article  PubMed  CAS  Google Scholar 

  • Touw DJ, Vinks AATMM, Heijerman HGM, Bakker W. Validation of tobramycin monitoring in adolescent and adult patients with cystic fibrosis. Therapeutic Drug Monitoring 15: 52–59, 1993

    Article  PubMed  CAS  Google Scholar 

  • Trang JM, Jacobs RF, Keams GL, Brown AL, Wells TG, et al. Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis. Antimicrobial Agents and Chemotherapy 28: 791–795, 1985

    Article  PubMed  CAS  Google Scholar 

  • Trang JM, Kidd L, Gruber W, Storch G, Demmler G, et al. Linear single-dose pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. Clinical Pharmacology and Therapeutics 53: 15–21, 1993

    Article  PubMed  CAS  Google Scholar 

  • Tremblay D, Dupront A, Ho C, Coussediere D, Lenfant B. Pharmacokinetics of cefpodoxime in young and elderly volunteers after single doses. Journal of Antimicrobial Chemotherapy 26 (Suppl. E): 21–28, 1990

    PubMed  CAS  Google Scholar 

  • Vogelstein B, Kowarski AA, Lietman PS. The pharmacokinetics of amikacin in children. Journal of Pediatrics 91: 333–339, 1977

    Article  PubMed  CAS  Google Scholar 

  • Wallace S. Altered plasma albumin in the newborn infant. British Journal of Clinical Pharmacology 4: 83–85, 1977

    Article  Google Scholar 

  • Wilson CB, Koup JR. Clinical pharmacology of extended-spectmm penicillins in infants and children. Journal of Pediatrics 106: 1049–1056, 1985

    Article  PubMed  CAS  Google Scholar 

  • Wilson JT, Keams GL, Murphy D, Yaffe SJ. Paediatric labelling requirements. Implications for pharmacokinetic studies. Clinical Pharmacokinetics 26: 308–325, 1994

    Article  PubMed  CAS  Google Scholar 

  • Wong VK, Wright HT, Ross LA, Mason WH, Inderlied CB, et al. Imipenem/cilastatin treatment of bacterial meningitis in children. Pediatric Infectious Disease Journal 10: 122–125, 1991

    Article  PubMed  CAS  Google Scholar 

  • Yaffe SJ, Gerbracht LM, Mosovich LL, Mattar ME, Danish M, et al. Pharmacokinetics of methicillin in patients with cystic fibrosis. Journal of Infectious Diseases 135: 828–831, 1977

    Article  PubMed  CAS  Google Scholar 

  • Yogev R, Kolling WM, Williams T. Pharmacokinetic comparison of intravenous and oral chloramphenicol in patients with Haemophilus influenzae meningitis. Pediatrics 67: 656–660, 1981

    PubMed  CAS  Google Scholar 

  • Zaske DE, Sawchuk RJ, Gerding DN, Strate RG. Increased dosage requirements of gentamicin in burn patients. Journal of Trauma 16: 824–828, 1976

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacy, University of Kentucky Hospital, Lexington, Kentucky, USA

    Dawn R. Butler

  2. University of Kentucky Medical Centre C-117, University of Kentucky, College of Pharmacy, 800 Rose Street, Lexington, Kentucky, 40536-0084, USA

    Robert J. Kuhn &  Mary H. H. Chandler

Authors
  1. Dawn R. Butler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert J. Kuhn
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mary H. H. Chandler
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Butler, D.R., Kuhn, R.J. & Chandler, M.H.H. Pharmacokinetics of Anti-Infective Agents in Paediatric Patients. Clin. Pharmacokinet. 26, 374–395 (1994). https://doi.org/10.2165/00003088-199426050-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-199426050-00005

Keywords

Search

Navigation